Berg D - Search Results

1

Pre-motor signs of PD are related to SN hyperechogenicity assessed by TCS in an elderly population.

Liepelt I, Behnke S, Schweitzer K, Wolf B, Godau J, Wollenweber F, Dillmann U, Gaenslen A, Di Santo A, Maetzler W, Berg D. Liepelt I, et al. Among authors: berg d. Neurobiol Aging. 2011 Sep;32(9):1599-606. doi: 10.1016/j.neurobiolaging.2009.10.004. Epub 2009 Nov 7. Neurobiol Aging. 2011. PMID: 19897277 Clinical Trial.

2

Does ultrasound disclose a vulnerability factor for Parkinson's disease?

Behnke S, Berg D, Becker G. Behnke S, et al. Among authors: berg d. J Neurol. 2003 Feb;250 Suppl 1:I24-7. doi: 10.1007/s00415-003-1104-0. J Neurol. 2003. PMID: 12761631 Review.

3

Screening for mutations of the ferritin light and heavy genes in Parkinson's disease patients with hyperechogenicity of the substantia nigra.

Felletschin B, Bauer P, Walter U, Behnke S, Spiegel J, Csoti I, Sommer U, Zeiler B, Becker G, Riess O, Berg D. Felletschin B, et al. Among authors: berg d. Neurosci Lett. 2003 Nov 27;352(1):53-6. doi: 10.1016/j.neulet.2003.08.026. Neurosci Lett. 2003. PMID: 14615048

4

Screening for mutations of the IRP2 gene in Parkinson's disease patients with hyperechogenicity of the substantia nigra.

Deplazes J, Schöbel K, Hochstrasser H, Bauer P, Walter U, Behnke S, Spiegel J, Becker G, Riess O, Berg D. Deplazes J, et al. Among authors: berg d. J Neural Transm (Vienna). 2004 Apr;111(4):515-21. doi: 10.1007/s00702-004-0125-z. J Neural Transm (Vienna). 2004. PMID: 15057521

5

Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease.

Berg D, Merz B, Reiners K, Naumann M, Becker G. Berg D, et al. Mov Disord. 2005 Mar;20(3):383-5. doi: 10.1002/mds.20311. Mov Disord. 2005. PMID: 15486999

6

Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease.

Hochstrasser H, Bauer P, Walter U, Behnke S, Spiegel J, Csoti I, Zeiler B, Bornemann A, Pahnke J, Becker G, Riess O, Berg D. Hochstrasser H, et al. Among authors: berg d. Neurology. 2004 Nov 23;63(10):1912-7. doi: 10.1212/01.wnl.0000144276.29988.c3. Neurology. 2004. PMID: 15557511

7

The role of alpha-synuclein gene multiplications in early-onset Parkinson's disease and dementia with Lewy bodies.

Hofer A, Berg D, Asmus F, Niwar M, Ransmayr G, Riemenschneider M, Bonelli SB, Steffelbauer M, Ceballos-Baumann A, Haussermann P, Behnke S, Krüger R, Prestel J, Sharma M, Zimprich A, Riess O, Gasser T. Hofer A, et al. Among authors: berg d. J Neural Transm (Vienna). 2005 Sep;112(9):1249-54. doi: 10.1007/s00702-004-0263-3. Epub 2004 Dec 29. J Neural Transm (Vienna). 2005. PMID: 15622440

8

Differentiation of Parkinson's disease and atypical parkinsonian syndromes by transcranial ultrasound.

Behnke S, Berg D, Naumann M, Becker G. Behnke S, et al. Among authors: berg d. J Neurol Neurosurg Psychiatry. 2005 Mar;76(3):423-5. doi: 10.1136/jnnp.2004.049221. J Neurol Neurosurg Psychiatry. 2005. PMID: 15716540 Free PMC article. Clinical Trial.

9

Substantia nigra hyperechogenicity as a marker of predisposition and slower progression in Parkinson's disease.

Schweitzer KJ, Hilker R, Walter U, Burghaus L, Berg D. Schweitzer KJ, et al. Among authors: berg d. Mov Disord. 2006 Jan;21(1):94-8. doi: 10.1002/mds.20669. Mov Disord. 2006. PMID: 16114024

10

Functional relevance of ceruloplasmin mutations in Parkinson's disease.

Hochstrasser H, Tomiuk J, Walter U, Behnke S, Spiegel J, Krüger R, Becker G, Riess O, Berg D. Hochstrasser H, et al. Among authors: berg d. FASEB J. 2005 Nov;19(13):1851-3. doi: 10.1096/fj.04-3486fje. Epub 2005 Sep 8. FASEB J. 2005. PMID: 16150804

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,424 results

Search Page

Filters